Trade Secrets

Genentech’s troubles highlight biosimilar trade secret risks

Two founders of JHL Biotech have recently been indicted for conspiracy to steal trade secrets from the Californian company, while two other individuals pleaded guilty to similar charges

Genentech’s troubles highlight biosimilar trade secret risks
Feds don’t need a ‘China Initiative’ to go after trade secret theft
3 Jul 2021

Feds don’t need a ‘China Initiative’ to go after trade secret theft

Saturday Opinion: American IP owners would be better served by a DOJ focus on bringing home blockbuster trade secrets cases regardless of nationality

For India and other countries, an IP waiver is a distraction not a solution to the covid-19 vaccine crisis
26 Jun 2021

For India and other countries, an IP waiver is a distraction not a solution to the covid-19 vaccine crisis

A TRIPs suspension will not provide the shot in the arm that millions of Indians need, but the country does have a major role to play in supplying vaccines to the world

Latest

View all
25 Jun 2021

Damages track upward in US trade secret litigation

But despite a growing emphasis on the topic and a move toward more remote working, overall caseload has been flat Read more

24 Jun 2021

Legislation to give the ITC more power in trade secrets cases raises many questions

The opportunity to shut out competitors after a 30-day investigation would be a powerful tool for businesses, but potentially a very dangerous one too Read more

23 Jun 2021

The proposed TRIPs covid waiver is a bad idea that could do a lot of good

The Long Read: With Big Pharma being blamed for the slow roll-out of vaccines in medium and low-income countries, Zilber IP’s Einav Zilber argues that the debate over suspending patents, trade secrets and other rights to increase access to jabs is really about the relationship between states and drug companies – and that these issues are not going away Read more

17 Jun 2021

Everything you need to know about the covid-19 IP waiver negotiations

With text-based discussions of a TRIPS suspension about to get underway, IAM highlights the key issues to be aware of. Read more

News

View all
8 May 2021

Biden’s backing for the covid vaccine IP waiver should concern all rights owners

This week’s unprecedented move raises a series of worrying questions and puts in doubt the administration’s commitment to fostering innovative activity Read more

19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

9 Nov 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome Read more

28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

Analysis

View all
16 Jun 2021

Why a two-speed corporate IP function is the way to keep up with digital

The Long Read: Re-engineering in-house teams to meet the new challenges posed by the rapidly evolving digital environment does not have to involve a wholesale teardown of existing structures, argue Jens Bordin and Karin Lersten of Konsert Strategy & IP. Instead, it could be more of a directed evolution Read more

14 Jun 2021

The IP dangers in life sciences collaborations and how to avoid them

Partnership agreements are a growing part of the biopharma R&D process, so anticipating potential pitfalls in such arrangements is vital Read more

9 Jun 2021

Research confirms trade secret protection now a major boardroom issue

Multi-jurisdictional survey of over 300 senior executives in six industries identifies cybersecurity and employee leaks as the two major vulnerabilities Read more

9 Jun 2021

Battle over aircraft start-up shows why Chinese investments fuel IP fears

Investors file Delaware lawsuit in bid to block IP deal with Chinese company Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more